Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients

Sepsis Clinical Trial

— PROFICIENT  

Official title:

Capnodynamic Monitoring of Cardiorespiratory Function in Patients Admitted to the Intensive Care Unit With COVID-19 Infection, Sepsis and Following Cardiac Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05082168
• Other study ID #: 2020/ETH00778
• Status: Recruiting
• Start date: February 1, 2021
• Est. completion date: July 1, 2023

Study information

• Verified date: October 2021
• Source: South West Sydney Local Health District
• Contact: Anders Aneman, Prof
• Phone: +61 (0)2 87383400
• Email: anders.aneman[@]health.nsw.gov.au
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Capnodynamic monitoring has the potential to offer continuous and non-invasive measurements of heart and lung function in patients requiring ventilation in an intensive care setting. Since mechanical ventilation with full patient synchronization is commonly used in ICU, capnodynamic monitoring can be immediately embedded in clinical care and compared to current methods of monitoring cardiac output, lung volumes and oxygen delivery. This observational study will explore capnodynamic monitoring in mechanically ventilated patients with a range of cardiorespiratory compromise.

Description:

This study aims to: 1. compare the estimation of cardiac output (CO) using the capnodynamic method (COEPBF) with contemporary reference methods; 2. compare the estimation of mixed venous oxygen saturation (SmvO2) with invasively obtained blood gas analyses; 3. generate observational data on end-expiratory lung volume (EELV) when ventilator settings, and in particular PEEP, are changed; 4. combine 1-3 to provide a physiological construct of cardiorespiratory function

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: July 1, 2023
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Respiratory tract infection:

1. confirmed or highly suspected viral or bacterial pneumonia

2. meeting ARF or ARDS criteria as outlines in the most recent Berlin ARDS consensus statement

3. age 18 years or above

4. arterial and central venous catheters have been inserted or will be inserted as part of routine clinical management

5. mechanical ventilation via an endotracheal tube is expected to continue for the day beyond day of admission

6. adequate transthoracic echocardiographic winds are available to measure the velocity time integral in the left ventricular outflow tract

7. analgosedation is administered as part of routine management of residual neuromuscular blockaded initiated outside ICU OR the administration of analgosedation and/or neuromuscular blockers at doses that achieve full patient-ventilator synchrony are considered part of routine clinical management

Sepsis:

1. admitted to ICU with a provisional or established diagnosis of septic shock as defined by the Sepsis-3 criteria

2. age 18 years or above

3. arterial and central venous catheters have been inserted or will be inserted as part of routine clinical management

4. mechanical ventilation via an endotracheal tube is expected to continue for at least another two hours

5. adequate transthoracic echocardiographic winds are available to measure the velocity time integral in the left ventricular outflow tract

6. analgosedation is administered as part of routine management of residual neuromuscular blockaded initiated outside ICU OR the administration of analgosedation and/or neuromuscular blockers at doses that achieve full patient-ventilator synchrony are considered part of routine clinical management

7. the administration of a fluid bolus (250 ml or 500 ml) is indicated as judged by the medical officer supervising routine management

Cardiac surgery:

1. admitted to ICU following cardiac surgery using cardiopulmonary bypass

2. age 18 years and above

3. arterial, central venous and pulmonary arterial catheters have been inserted or will be inserted as part of routine clinical management

4. mechanical ventilation via an endotracheal tube is expected to continue for at least another two hours

5. analgosedation is administered as part of routine management of residual neuromuscular blockade initiated intraoperatively OR the administration of analgosedation and/or neuromuscular blockers at doses that achieve full patient-ventilator synchrony are considered part of routine clinical management

6. the administration of a fluid bolus (250 ml or 500 ml) is indicated as judged by the medical officer supervising routine postoperative management Exclusion Criteria:

In all cohorts:

1. age under 18 years

2. known pregnancy

3. arterial and central venous catheters are not indicated as part of routine care

4. known severe valvulopathy

5. ongoing or imminent need for mechanical circulatory support

6. severe haemodynamic instability with imminent transfer for intervention(s) outside ICU

7. patient is not for full active management in ICU

8. patient is not expected to live beyond the day of admission

9. patient is re-admitted to ICU within the same index hospital admission

10. it is not possible to achieve full patient-ventilator synchrony

Related Conditions & MeSH terms

• Acute Respiratory Infection
• Infections
• Postoperative Respiratory Distress
• Respiratory Tract Infections
• Sepsis

Intervention

Device:
• Capnodynamic monitoring
In patients fully synchronized with mechanical ventilation, the capnodynamic method calculates the effective pulmonary blood flow, the end-expiratory lung volume and estimates the mixed venous oxygen saturation. The capnodynamic method uses short inspiratory or expiratory pauses to induce small changes in CO2 concentration the enable the mole balance to be resolved for the capnodynamic equation: ELV x [(FACO2(n)-FACO2(n-1)] = delta(n) x EPBF [CvCO2(n)] - VTCO2.

Locations

Country	Name	City	State
Australia	Intensive Care Unit, Liverpool Hospital, South Western Sydney Local Health District	Liverpool	New South Wales

Sponsors (1)

Lead Sponsor	Collaborator
South West Sydney Local Health District

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Correlation between capnodynamic effective pulmonary blood flow and cardiac output measured by pulmonary artery thermodilution or echocardiography	Capnodynamic measurements of effective pulmonary blood flow are compared with contemporaneously obtained cardiac output measurements using clinical reference methods	Through study completion, an average of 1 year
Primary	Correlation between capnodynamic estimates of mixed venous oxygen saturation and blood gas analysis of blood obtained from the pulmonary artery pulmonary.	Capnodynamic estimates of mixed venous oxygen saturation are compared with contemporaneously obtained blood gases from the pulmonary artery catheter	Through study completion, an average of 1 year
Primary	Prediction by capnodynamic monitoring of combined changes in end expiratory lung volume and effective pulmonary blood flow to assess changes in pulmonary gas exchange during various levels of PEEP	At three different levels of PEEP, the interactions between end expiratory lung volume and effective pulmonary blood flow will be assessed and correlated to changes in arterial partial pressure of oxygen and carbon dioxide	Through study completion, an average of 1 year